Pfizer weighing sale of Hospira's pump business: Bloomberg

Pfizer weighing sale of Hospira's pump business: Bloomberg

(Reuters) – Drugmaker Pfizer Inc is thinking approximately selling hospital products maker Hospira's infusion pump business for approximately $2 billion, Bloomberg reported, citing people familiar with the matter.

Talks are said to be at an early stage, Bloomberg reported on Wednesday. (

Pfizer closed its $15 billion acquisition of Hospira, which makes biosimilars & generic versions of injectable drugs, in September.

p> A Pfizer spokeswoman declined to comment.

Infusion pumps are computerized & are designed to deliver medications directly into patients' bloodstreams.

In November, Pfizer said it would buy Botox maker Allergan Plc in a deal worth $160 billion, which would create the world's largest drugmaker.

(Reporting by Anya George Tharakan in Bengaluru; Editing by Sunil Nair)

Health Care IndustryMergers, Acquisitions & TakeoversHospiraBloomberginfusion pumpPfizer Inc

Source: “Reuters”

Share and Enjoy

  • Facebook
  • Twitter
  • Delicious
  • LinkedIn
  • StumbleUpon
  • Add to favorites
  • Email
  • RSS